Advertisement

Search Results for "Changing Doxercalciferol To Calcitriol Conversion"

21:59 EDT 23rd May 2013 | BioPortfolio

Original Source: Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.

We compared the effects of calcitriol and doxercalciferol, in combination with either calcium carbonate or sevelamer, on bone, mineral, and fibroblast growth factor-23 (FGF-23) metabolism in patients with secondary hyperparathyroidism. A total of 60 pediatric patients treated with peritoneal dialysis were randomized to 8 months of therapy with either oral calcitriol or doxercalciferol, combined with either calcium carbonate or sevelamer. Bone formation rates decreased during therapy and final values were wi...

Matching Channels

Conversion Disorder

Dialysis - News, Views, Blogs

In medicine, dialysis is a process for removing waste and excess water from the blood, and is primarily used to provide an artificial replacement for lost kidney function in people with renal failur...

Disorders of Calcium Concentration

Calcium (Ca) is required for the proper functioning of muscle contraction, nerve conduction, hormone release, and blood coagulation. In addition, proper Ca concentration is required for various othe...

Menopause

The menopause is a natural event for all women; the ovaries no longer produce estrogen and progesterone. This can be due to natural aging (usual age of onset is 51 years), or through chemotherapy an...

COPD

COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus...

Matching News

Rockwell Heads Into 2013 With Major Catalysts

By Brian L. Wilson:Shares of Rockwell Medical (NASDAQ: RMTI) are still on the mend after a brief dip in November 2012 that caused shares to drop as low as $5.18 following the release of mixed third qu...

Calcitriol restores renovascular function in estrogen-deficient rats through downregulation of cyclooxygenase-2 and the thromboxane-prostanoid receptor

Malvern Federal Bancorp, Inc. Announces Approval of Plan of Conversion and Reorganization; Conversion Expected to Close October 11, 2012

PAOLI, Pa., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Malvern Federal Bancorp, Inc. (the "Company") (Nasdaq:MLVF), the holding company for Malvern Federal Savings Bank (the "Bank"), announced today that the...

Rockwell Medical: Q3 Expenses Jump, Calcitriol Launch Pushed Back Again

By Brian Marckx:Rockwell Medical (RMTI) reported results for Q3 ending September 30, 2012, on November 8th. Aside from the 6% revenue growth, financial results were significantly worse than we had exp...

Biocatalytic conversion of lignocellulose to platform chemicals

Naturally occurring lignocellulose can be used as a renewable resource for the sustainable production of platform chemicals that can in turn be converted to valuable fine chemicals, polymers, and fuel...

Dr. Mike Hamilton of Inception Chiropractic Websites Announces the Release of Conversion Optimized Chiropractic Websites

Clinton, IA (PRWEB) April 04, 2013 Internet marketing expert, Dr. Mike Hamilton, has recently announced the launch of conversion optimized chiropractic websites. According to Dr. Hamilton the new...

Conversion of human fibroblasts to angioblast-like progenitor cells

Human fibroblasts undergo conversion to angioblast-like progenitors and then to endothelial cells by brief exposure to pluripotency factors, which is then followed by differentiation.

Incorrect Metric Conversion in: Bone Density Screening Intervals for Osteoporosis: One Size Does Not Fit All

Incorrect Metric Conversion: In a Viewpoint entitled, “Bone Density Screening Intervals for Osteoporosis: One Size Does Not Fit All,” published in the June 27, 2012, issue of JAMA (2012;307[24]:25...

Matching PubMed Articles

Differential Effects of Oral Doxercalciferol (Hectorol®) or Paricalcitol (Zemplar®) in the Cyp27b1-Null Mouse Model of Uremia.

Background/Aims: Kidney disease patients experience declining calcitriol levels and develop secondary hyperparathyroidism (SHPT). Animal models of uremia based on 5/6 nephrectomy (NTX) do not consiste...

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.

We compared the effects of calcitriol and doxercalciferol, in combination with either calcium carbonate or sevelamer, on bone, mineral, and fibroblast growth factor-23 (FGF-23) metabolism in patients...

Vitamin D metabolism and action in the prostate: implications for health and disease.

Prostate cancer (PCa) is the second most common cancer in men worldwide. Epidemiological, molecular, and cellular studies have implicated vitamin D deficiency as a risk factor for the development and/...

Furan approach to vitamin D analogues. Synthesis of the A-ring of calcitriol and 1α-hydroxy-3-deoxyvitamin D(3).

The A-rings of calcitriol (1α,25-dihydroxyvitamin D(3)) and 1α-hydroxy-3-deoxyvitamin D(3) were synthesized using the furan approach. The critical steps in the synthesis of the A-ring of calcitriol...

Switch from calcitriol to paricalcitol in secondary hyperparathyroidism of hemodialysis patients: Responsiveness is related to parathyroid gland size.

Paricalcitol is more effective than calcitriol in hemodialysis patients (HD) with secondary hyperparathyroidism (SHPT), but it is not effective in some of them. We have investigated the relationship b...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement